BioCryst Pharmaceuticals, Inc.: BioCryst Sharpens Scientific Focus on External Innovation with Wind Down of Internal Discovery Programs and Closure of Birmingham Research Facility

Advances strategic shift toward a disciplined research model prioritizing external innovation to accelerate rare disease pipeline growth- -Completes enrollment in Phase 3 ALPHA-ORBIT for navenibart ...
Barron's

Evolution Global Acquisition Corp. Wt

Evolution Global Acquisition Corp. is a blank check company, which engages in the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or ...